Melt Pharmaceuticals, Inc. — Form D/A

Melt Pharmaceuticals, Inc. of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2023-12-11. The offering totals $30.0M, of which $20.2M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2023-12-11
• Form: D/A
• Accession: 0001767398-23-000006
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $30.0M
• Amount sold: $20.2M
• Remaining: $9.8M
• Investors: 272
• Date of first sale: 2023-07-28
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-489452

Issuer

• Name: Melt Pharmaceuticals, Inc.
• CIK: 0001767398
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2019
• Address: 12264 EL CAMINO REAL, SUITE 350 12264 El Camino Real, Suite 350, SAN DIEGO, CA, 92130
• Phone: 8587044042

Officers, directors & promoters (13)

Other filings by this issuer (10)

More

• CIK 1767398 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search